IRIS

Perchlorate (ClO4) and Perchlorate Salts

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (22 pp, 157 K) Last Updated: 02/18/2005

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Endocrine 7 x 10 -4 Radioactive iodide uptake inhibition (RAIU) in the thyroid NOEL : 7 x 10-3
mg/kg-day
10 High

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (22 pp, 157 K) Last Updated: 02/18/2005
Information reviewed but value not estimated.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (22 pp, 157 K) Last Updated: 02/18/2005

WOE Characterization Framework for WOE Characterization
Not likely to be carcinogenic to humans Revised Draft Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1999)
Basis:
  • Under U.S. EPAs 1999 Draft Revised Guidelines for Carcinogen Risk Assessment, perchlorate is not likely to pose a risk of thyroid cancer in humans, at least at doses below those necessary to alter thyroid hormone homeostasis, based on the hormonally-mediated mode of action in rodent studies and species differences in thyroid function.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (22 pp, 157 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (22 pp, 157 K)

Not assessed under the IRIS Program.


Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.